Skip to main content

Table 2 Imaging features of DCIS, mIDC, and IDC

From: The role of MRI and clinicopathologic features in predicting the invasive component of biopsy-confirmed ductal carcinoma in situ

 

DCIS (n = 112)

mIDC (n = 50)

IDC (n = 44)

P value

Mammography

 Parenchymal density

   

0.492

  Fatty

20 (17.9)

8 (16.0)

11 (25.0)

 

  Dense

92 (82.1)

42 (84.0)

33 (75.0)

 

 Calcification

   

0.025

  Present

65 (58.0)

40 (80.0)

29 (65.9)

 

  Absent

47 (42.0)

10 (20.0)

15 (34.1)

 

MRI

 BPE

   

0.145

  Minimal or mild

78 (69.6)

39 (78.0)

37 (84.1)

 

  Moderate or marked

34 (30.4)

11 (22.0)

7 (15.9)

 

 Multifocality

   

> 0.999

  Yes

5 (4.5)

2 (4.0)

1 (2.3)

 

  No

107 (95.5)

48 (96.0)

43 (97.7)

 

 Multicentricity

   

0.470

  Yes

7 (6.3)

1 (2.0)

1 (2.3)

 

  No

105 (93.8)

49 (98.0)

43 (97.7)

 

 Type of lesion

   

0.053

  Non-visualization

11 (9.8)

1 (2.0)

0 (0)

 

  Mass

50 (44.6)

18 (36.0)

19 (43.2)

 

  NME

51 (45.5)

31 (62.0)

25 (56.8)

 
  1. Data values indicate the number of patients (with percentages in parentheses), the mean ± standard deviation, or the median with range.
  2. DCIS ductal carcinoma in situ; mIDC microinvasive ductal carcinoma; IDC invasive ductal carcinoma; BPE background parenchymal enhancement; NME non-mass enhancement